Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms

Cédric Bousquet1, Éric Sadou2, Julien Souvignet1

  • 1INSERM, U1142, LIMICS, F-75006, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1142, LIMICS, F-75006, Paris, France; Université Paris 13, Sorbonne Paris Cité, LIMICS, (UMR_S 1142), F-93430, Villetaneuse, France; University of Saint Etienne, Department of Public Health and Medical Informatics, Saint-Etienne, France.

Insights

Formal definitions were added to the Medical Dictionary for Regulatory Activities (MedDRA) to enable semantic reasoning and overcome its hierarchical limitations. This "ontologized" MedDRA, called OntoADR, facilitates novel category discovery for adverse drug reaction data mining.

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Medical Informatics and Ontologies
  • Computational Linguistics and Terminology

Background:

  • The Medical Dictionary for Regulatory Activities (MedDRA) is crucial for coding adverse drug reactions (ADRs) and signal detection.
  • MedDRA's hierarchical structure limits flexible searching and the discovery of novel adverse event categories.
  • Integrating formal definitions can enhance MedDRA's utility for semantic reasoning and data mining.

Purpose of the Study:

  • To develop an "ontologized" version of MedDRA, named OntoADR, by associating formal definitions with its terms.
  • To enable semantic reasoning and overcome the constraints of MedDRA's predefined categories.
  • To facilitate the retrieval of terms based on case definitions, potentially revealing novel categories.

Main Methods:

  • Converted MedDRA's five-level hierarchy into a subsumption tree.
  • Developed formal definitions for MedDRA terms using multiple approaches: mapping to SNOMED-CT, semi-automatic algorithms, and manual curation.
  • Created an OWL (Web Ontology Language) file, OntoADR, to store the formalized MedDRA terms and definitions.

Main Results:

  • Successfully created OntoADR, an "ontologized" version of MedDRA with associated formal definitions.
  • Demonstrated a method for enhancing MedDRA's terminological organization through formal semantics.
  • Identified challenges and limitations inherent in the process of ontologizing MedDRA.

Conclusions:

  • The OntoADR project represents a significant step towards enabling semantic reasoning with MedDRA.
  • Formal definitions enhance MedDRA's capability for data mining and adverse drug reaction signal discovery beyond its inherent structure.
  • Further development is needed to address the identified problems and limitations in creating a comprehensive ontologized MedDRA.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.3K
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
295